Erin Sieck

Dr. Erin Sieck

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2020 in Journal of Binocular Vision and Ocular Motility
Verified
Journal Article
Closed access
ESErin Sieck
Erin Sieck
AMAnirudh Madabhushi
Anirudh Madabhushi
JPJennifer L. Patnaik
Jennifer L. Patnaik
JJJennifer L. Jung
Jennifer L. Jung
ALAnne M. Lynch
Anne M. Lynch
JSJasleen K. Singh
Jasleen K. Singh
The purpose of this study is to compare surgical outcomes of recession, anteriorization, and myotomy for the treatment of inferior oblique overaction (IOOA). A retrospective chart review of all pat...

23 August 2023 in Current Ophthalmology Reports
Verified
Journal Article
Open access
PDF file
ALA. M. Levin
A. M. Levin
ESErin Sieck
Erin Sieck
Purpose of Review: In this article, we discuss the pathophysiology underlying intraocular pressure elevation associated with corticosteroid use as well as targeted therapies for treatment. Recent Findings: Several signaling pathways at the level of the trabecular meshwork are altered by steroid exposure. A pre-existing diagnosis of glaucoma is the best-established risk factor for development of steroid-associated ocular hypertension. Topical, local, and systemic steroids have all been associated with ocular hypertension. Summary: Current management is directed at steroid-sparing alternatives to treatment, steroid cessation, IOP-lowering medications, and interventional lasers and surgery.

1 January 2020 in Therapeutic Advances in Ophthalmology
Verified
Journal Article
Open access
PDF file
ESErin Sieck
Erin Sieck
LZLeonid Zukin
Leonid Zukin
JPJennifer L. Patnaik
Jennifer L. Patnaik
ALAnne M. Lynch
Anne M. Lynch
PKPeggy Kelley
Peggy Kelley
JSJasleen K. Singh
Jasleen K. Singh
Congenital dacrocystocele with potential for dacryocystitis are common ophthalmic findings in children. There are multiple surgical approaches to open the mucocele. In this study, we look at the financial impact of these different approaches. A retrospective chart review of 17 patients with dacrocystocele or dacryocystitis was performed. We examined four approaches: (1) bedside nasal endoscopy with marsupialization of nasolacrimal duct (NLD) cyst, (2) surgically performed nasal endoscopy with marsupialization of NLD cyst, (3) NLD probe, and (4) a combination of procedures. Cost of the procedure and length of anesthesia were collected. Reoccurrence of symptoms and disease post-procedure were also collected. The lowest cost billed procedure was bedside nasal endoscopy performed by an otolaryngologist (US$435; n = 1). A nasal endoscopy (n = 2) performed in the operating room (OR) had an average OR fee of US$14,557 [standard deviation (SD): US$7598] for 108.5 (SD: 87.0) min of operating time. An NLD probe (n = 5) performed by pediatric ophthalmologists resulted in an average OR fee of US$5540 (SD: US$1752) for 31.0 min (SD: 8.6 min) of operating time. A combination of both nasal endoscopy and NLD probing (n = 9) had an average OR fee US$10,325 (SD: US$4137) for 69 min (SD: 34.5 min) of operating time. This is the first study looking at cost benefit of four different approaches to treating dacrocystoceles/dacryocystitis. A NLD probe was a low-cost OR intervention and had the shortest operating time. The combination procedure was more cost-effective than nasal endoscopy or NLD probing alone.

1 January 2026 in Case Reports in Ophthalmological Medicine
Verified
Journal Article
Open access
DSDan Spiegelman
Dan Spiegelman
ISIsabella Song
Isabella Song
ESErin Sieck
Erin Sieck
Purpose: This study is aimed at describing the use of suprachoroidal triamcinolone injection for the treatment of refractory uveitis‐associated ocular hypotony presumed secondary to ciliary body shutdown. Methods: We report a case of a 58‐year‐old woman with a 26‐year history of idiopathic, noninfectious bilateral panuveitis complicated by recurrent cystoid macular edema and a steroid‐induced ocular hypertension. After treatment with an intravitreal dexamethasone implant and an Ahmed glaucoma valve, she developed persistent hypotony in the right eye with intraocular pressure (IOP) of 2–4 mmHg despite controlled inflammation. Evaluation with gonioscopy and ultrasound biomicroscopy revealed no cyclodialysis cleft or cyclitic membranes. Prior treatments, including topical steroids, repeat dexamethasone implant, Ahmed valve revision, and serial anterior chamber viscoelastic injections, produced only transient improvement. Suprachoroidal triamcinolone (40 mg) was administered. Results: Before injection, IOP ranged from 2 to 6 mmHg. Following treatment, IOP remained ≥ 6 mmHg for approximately 2 months. Best corrected visual acuity improved from 20/80 to 20/50, and additional viscoelastic injections were not required during this period. Numerical hypotony recurred 8 months later. Conclusion: Suprachoroidal triamcinolone may represent a targeted treatment for refractory uveitis‐associated hypotony when ciliary body dysfunction is suspected and other steroid delivery routes are limited. Further study is needed to evaluate durability and broader applicability.

24 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CICristos Ifantides
Cristos Ifantides
HBHernan Bejar
Hernan Bejar
JPJennifer L. Patnaik
Jennifer L. Patnaik
ESErin Sieck
Erin Sieck
MPMina Pantcheva
Mina Pantcheva
WMWILLIAM MCCOLLUM
WILLIAM MCCOLLUM
Background/Objectives: Black and Afro-Latinx communities have a higher propensity for more-severe glaucoma at a younger age. This study aimed to use the Kahook Dual Blade (KDB) to treat all glaucoma subtypes and severity levels in this historically underserved community. Materials and Methods: This study involved a retrospective analysis of surgical case records, with follow-up through 20 months. The subjects were glaucoma patients at Hospital Elias Santana in Santo Domingo, Dominican Republic. Inclusion criteria were age >18 years and a minimum follow-up of 1 year after surgery. All glaucoma subtypes and disease severities were included, including previous glaucoma procedures. Sequential patients undergoing KDB goniotomy alone or in combination with phacoemulsification cataract surgery were assessed. IOP data and number of medications were collected at specific time points: baseline, postoperative day 1, postoperative week 1, and postoperative months 1, 3, 6, 12, 16, and 20. Surgical outcome was determined using IOP and number of medications. Success was defined as either a 20% or more reduction in IOP or a decrease in at least one topical therapy. Recorded postoperative complications were hyphema, ocular hypertension, and need for additional glaucoma surgery. Results: A total of 90 eyes from 90 patients were included. A total of 100% of the patient population was Black or Afro-Latinx. The most common glaucoma subtype was primary open-angle (76.7%). Most of the eyes had severe glaucoma (53.3%). The mean preoperative baseline IOP was 20.5 mmHg. The mean postoperative IOP from all time points ranged from 12.9 to 13.5 mmHg (all time points were significantly lower than baseline IOP, p < 0.0001). A mean reduction in IOP percent of at least 31.5% was seen at every time point. There was a mean reduction of two medications by postoperative month 20. Surgical success was achieved in 95.6% of patients at postoperative month 1 and remained high throughout the study period (95.4% at month 20). Conclusions: KDB goniotomy achieved successful IOP and medication reduction across all levels of glaucoma severity. Surgical success rates were maintained to 20 months. While MIGS has historically been used as an intervention in mild-to-moderate glaucoma, our study results show that the KDB can play a significant role in all stages of glaucoma, including severe. MIGS should be considered as a favorable intervention in all disease severities in Black and Afro-Latinx communities around the world.

18 July 2024 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
YXYu Xia
Yu Xia
NBNathaniel A. Blecher
Nathaniel A. Blecher
PCPhilip L. Custer
Philip L. Custer
ESErin Sieck
Erin Sieck
Purpose: To report the observation that the efficacy of topical glaucoma treatment improved after surgical correction of ectropion in a 71-year-old male with a known history of glaucoma. Observations: The patient initially presented for tearing and lid malposition and was found to have bilateral elevated intraocular pressures (IOP) in addition to bilateral lower eyelid ectropion. IOP control was initially prioritized over ectropion repair, with IOP remaining elevated despite topical glaucoma treatment and selective laser trabeculoplasty. Sequential unilateral ectropion repair was then carried out, with topical glaucoma treatment resumed after the first repair. It was observed that the IOP improved with topical glaucoma treatment on each side after ectropion repair, despite no changes to medications nor dosing. Conclusions and importance The efficacy of topical glaucoma treatment is dependent on drop availability and absorption. While recent efforts to increase drop efficacy have been focused on engineering formulations that increase retention or corneal penetration, our case highlights that in selected glaucoma patients, correction of lid malposition may serve as an effective way to improve drop efficacy.